For medical or scientific enquiries or other enquiries, please contact us here:

Contact

More than 110 years of innovation

Better outcomes for more patients.

About

Who we are.

Friedrich Merz cared deeply about helping people. That is why the 24-year-old German pharmacist and chemist founded the Merz company in 1908. Now, more than 110 years later, we at Merz Therapeutics, as part of the Merz Group, are proud of our broad portfolio of well-established products that treat severe health conditions such as movement disorders and neurological conditions. It is our ambition to really make a difference for patients and healthcare providers. Therefore, in the tradition of our founder, when we develop new products, technologies or services, we always first ask ourselves the question “What is needed?”.

Our products treat fundamental impairments in patients’ daily life. We cover a broad spectrum of therapy options and seek to address the specific needs of patients with the following:

Neuromuscular disorders and conditions Icon

Neuromuscular disorders and conditions

such as cervical dystonia, upper limb spasticity, blepharospasm, hemifacial spasm

Chronic severe drooling (sialorrhea) Icon

Chronic severe drooling (sialorrhea)

in children and adults with neurological conditions

Merz Therapeutics is part of the Merz Group, a privately held, family-owned company that has dedicated more than 110 years to developing innovations that meet patient and customer needs. The Merz Group is a global, diversified company based in Frankfurt, Germany, with the three businesses; Merz Aesthetics, Merz Therapeutics and Merz Consumer Care. The company employs more than 3.000 people in 28 countries worldwide.

Learn more about Merz Group

Merz Therapeutics

Working together for the good of patients

Every day our employees use their skills to address patients’ unmet needs. To reach as many people as possible our marketing, medical and field presence operates throughout Europe, North America and Russia. Also, we rely on our experienced and successful global distribution partner management. In order to provide innovative products that meet the highest quality standards, our R&D department cooperates with a recognised expert network and turns these insights into solutions – such as in our state-of-the-art neurotoxin biotechnology production site.

Facts and figures

80

Affiliates & sales in more than 80 countries

2

Production sites Dessau & Reinheim (Germany)

700

>700 employees around the world

Vision and values

What we stand for.

It is our vision that based on over 110 years of experience, we will be a global leader in therapeutic innovations that empower patients to live life to the full and achieve their individual goals. Driven by our passion, we do everything to bring better outcomes to more patients. We relentlessly pursue unmet needs and engage all stakeholders to deliver meaningful value. In doing so, we align all our thinking and actions with these principles.

Bulb Icon

Persist in innovation

Innovation is the lifeblood of our company and the key to our continued growth. We effectively identify and relentlessly pursue the scientific developments and strategic investments that will drive our long-term success. We support Merz’s culture of innovation by empowering employees, rewarding risk-taking and encouraging personal accountability.

Commit to customers and colleagues

In all our work, both with customers and colleagues, we build lasting relationships based on trust, respect and integrity. We strive to demonstrate our open and collegial company culture at every opportunity, and we actively seek feedback from our partners, knowing that it makes our relationships stronger and more productive.

Deliver trusted results

We are proud to share the Merz heritage of providing high quality and scientifically backed products and services for over a hundred years. We uphold high ethical standards throughout our company ensuring that our promises, work and results are trusted for years to come. We take a long-term view and we are committed to delivering profitability and financial sustainability for many years to come.